Dupuytren's Contracture and Treatments
Dupuytren's Contracture and Treatments is a research topic within Rheumatology. Science Explorer counts 8k research works in it since 1950. 7.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the treatment, pathogenesis, and epidemiology of Dupuytren's disease, including the use of Collagenase Clostridium Histolyticum, fasciectomy, needle fasciotomy, and radiotherapy. It also explores genetic susceptibility, Wnt signaling, myofibroblasts, TGF-ß1 stimulation, and contracture recurrence.
- Collagenase Clostridium Histolyticum
- Fasciectomy
- Needle Fasciotomy
- Wnt Signaling
- Epidemiology
- Genetic Susceptibility
- Radiotherapy
- Myofibroblasts
- TGF-ß1 Stimulation
- Contracture Recurrence
- Research works
- 8k fractional, since 1950
- In the world top 10%
- 587 per year above
- Top-10% rate
- 7.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +7% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Dupuytren's Contracture and Treatments research?
By volume, the United States and Germany publish the most (304 and 95 works in 2022–2025).
By volume, 2022–2025
- 1 United States 304 works
- 2 Germany 95 works
- 3 India 83 works
- 4 China 82 works
- 5 United Kingdom 70 works
- 6 France 53 works
- 7 Japan 43 works
- 8 Italy 36 works
- 9 Spain 31 works
- 10 Türkiye 31 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Dupuytren's Contracture and Treatments research?
By volume in 2022–2025, University of Missouri–Kansas City publishes the most Dupuytren's Contracture and Treatments research, followed by Harvard University and Charité - Universitätsmedizin Berlin.
By volume, 2022–2025
- 1 University of Missouri–Kansas CityUnited States 6 works
- 2 Harvard UniversityUnited States 5 works
- 3 Charité - Universitätsmedizin BerlinGermany 4 works
- 4 Mayo Clinic in ArizonaUnited States 4 works
- 5 All India Institute of Medical SciencesIndia 4 works
- 6 Paracelsus Medizinische PrivatuniversitätGermany 4 works
- 7 University of UtahUnited States 4 works
- 8 Nuremberg HospitalGermany 4 works
- 9 University of California, San FranciscoUnited States 3 works
- 10 Sağlık Bilimleri ÜniversitesiTürkiye 3 works
Where is Dupuytren's Contracture and Treatments research done?
The largest centres of Dupuytren's Contracture and Treatments research in 2022–2025 are London (United Kingdom), Paris (France), Beijing (China) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in London.
Largest cities, 2022–2025
Where it is the local speciality
- LondonGB · 21.5 works2.0×
Location quotient: how much more of its research is in Dupuytren's Contracture and Treatments than the world average.
Is Dupuytren's Contracture and Treatments research growing?
Output in 2018–2022 was 7% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Dupuytren's Contracture and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.